breast cancer, AI and NHS

NHS clinics will use artificial intelligence to screen for breast cancer in a massive “landmark” trial. Almost 700,000 ...
Novartis’ Kisqali (ribociclib) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat a ...
A major trial aiming to transform breast cancer screening with artificial intelligence has been launched, with almost 700,000 ...